| Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination J Yu, MD Green, S Li, Y Sun, SN Journey, JE Choi, SM Rizvi, A Qin, ... Nature medicine 27 (1), 152-164, 2021 | 529 | 2021 |
| Cardiac events after radiation therapy: combined analysis of prospective multicenter trials for locally advanced non–small-cell lung cancer RT Dess, Y Sun, MM Matuszak, G Sun, PD Soni, L Bazzi, VL Murthy, ... Journal of Clinical Oncology 35 (13), 1395, 2017 | 321 | 2017 |
| Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome P Panwalkar, J Clark, V Ramaswamy, D Hawes, F Yang, C Dunham, ... Acta neuropathologica 134, 705-714, 2017 | 199 | 2017 |
| Integrated survival estimates for cancer treatment delay among adults with cancer during the COVID-19 pandemic HE Hartman, Y Sun, TP Devasia, EC Chase, NK Jairath, RT Dess, ... JAMA oncology 6 (12), 1881-1889, 2020 | 89 | 2020 |
| Inhibition of 2-hydroxyglutarate elicits metabolic reprogramming and mutant IDH1 glioma immunity in mice P Kadiyala, SV Carney, JC Gauss, MB Garcia-Fabiani, S Haase, ... The Journal of clinical investigation 131 (4), 2021 | 84 | 2021 |
| Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis AU Kishan, Y Sun, H Hartman, TM Pisansky, M Bolla, A Neven, A Steigler, ... The lancet oncology 23 (2), 304-316, 2022 | 77 | 2022 |
| Association of presalvage radiotherapy PSA levels after prostatectomy with outcomes of long-term antiandrogen therapy in men with prostate cancer RT Dess, Y Sun, WC Jackson, NK Jairath, AU Kishan, DG Wallington, ... JAMA oncology 6 (5), 735-743, 2020 | 68 | 2020 |
| Prostate radiotherapy with adjuvant androgen deprivation therapy (ADT) improves metastasis-free survival compared to neoadjuvant ADT: an individual patient meta-analysis DE Spratt, S Malone, S Roy, S Grimes, L Eapen, SC Morgan, J Malone, ... Journal of Clinical Oncology 39 (2), 136, 2021 | 67 | 2021 |
| Development and validation of a clinical prognostic stage group system for nonmetastatic prostate cancer using disease-specific mortality results from the international staging … RT Dess, K Suresh, MJ Zelefsky, SJ Freedland, BA Mahal, ... JAMA oncology 6 (12), 1912-1920, 2020 | 59 | 2020 |
| Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials A Esteva, J Feng, D van der Wal, SC Huang, JP Simko, S DeVries, ... NPJ digital medicine 5 (1), 71, 2022 | 51 | 2022 |
| Systemic delivery of an adjuvant CXCR4–CXCL12 signaling inhibitor encapsulated in synthetic protein nanoparticles for glioma immunotherapy MS Alghamri, K Banerjee, AA Mujeeb, A Mauser, A Taher, R Thalla, ... ACS nano 16 (6), 8729-8750, 2022 | 45 | 2022 |
| Early HPV ctDNA kinetics and imaging biomarkers predict therapeutic response in p16+ oropharyngeal squamous cell carcinoma Y Cao, CT Haring, C Brummel, C Bhambhani, M Aryal, C Lee, M Heft Neal, ... Clinical Cancer Research 28 (2), 350-359, 2022 | 45 | 2022 |
| An analysis of knowledge-based planning for stereotactic body radiation therapy of the spine JJ Foy, R Marsh, RK Ten Haken, KC Younge, M Schipper, Y Sun, D Owen, ... Practical radiation oncology 7 (5), e355-e360, 2017 | 44 | 2017 |
| Circulating microRNAs as biomarkers of radiation-induced cardiac toxicity in non-small-cell lung cancer PG Hawkins, Y Sun, RT Dess, WC Jackson, G Sun, N Bi, M Tewari, ... Journal of Cancer Research and Clinical Oncology 145, 1635-1643, 2019 | 39 | 2019 |
| Radiation-induced insufficiency fractures after pelvic irradiation for gynecologic malignancies: a systematic review N Razavian, A Laucis, Y Sun, DE Spratt, D Owen, C Schonewolf, S Uppal, ... International Journal of Radiation Oncology* Biology* Physics 108 (3), 620-634, 2020 | 38 | 2020 |
| Local failure events in prostate cancer treated with radiotherapy: a pooled analysis of 18 randomized trials from the meta-analysis of randomized trials in cancer of the … TM Ma, FI Chu, H Sandler, FY Feng, JA Efstathiou, CU Jones, ... European urology 82 (5), 487-498, 2022 | 35 | 2022 |
| Serum microRNA signature predicts response to high-dose radiation therapy in locally advanced non-small cell lung cancer Y Sun, PG Hawkins, N Bi, RT Dess, M Tewari, JWD Hearn, JA Hayman, ... International Journal of Radiation Oncology* Biology* Physics 100 (1), 107-114, 2018 | 33 | 2018 |
| A phase 2 study of dose-intensified chemoradiation using biologically based target volume definition in patients with newly diagnosed glioblastoma MM Kim, Y Sun, MP Aryal, HA Parmar, M Piert, B Rosen, CS Mayo, ... International Journal of Radiation Oncology* Biology* Physics 110 (3), 792-803, 2021 | 32 | 2021 |
| Addition of docetaxel to androgen receptor axis–targeted therapy and androgen deprivation therapy in metastatic hormone-sensitive prostate cancer: a network meta-analysis S Roy, R Sayyid, F Saad, Y Sun, K Lajkosz, M Ong, Z Klaassen, S Malone, ... European Urology Oncology 5 (5), 494-502, 2022 | 27 | 2022 |
| Evaluation of social determinants of health and prostate cancer outcomes among black and white patients: a systematic review and meta-analysis RA Vince, R Jiang, M Bank, J Quarles, M Patel, Y Sun, H Hartman, ... JAMA network open 6 (1), e2250416-e2250416, 2023 | 23 | 2023 |
